prednisolone has been researched along with Myofibromatosis in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Myofibromatosis: A condition characterized by multiple formations of myofibromas (LEIOMYOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infantile myofibromatosis is the most common fibrous tumor of infancy." | 2.42 | Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy. ( Gandhi, MM; Levitt, GA; Nathan, PC; Weitzman, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, MM | 1 |
| Nathan, PC | 1 |
| Weitzman, S | 1 |
| Levitt, GA | 1 |
1 review available for prednisolone and Myofibromatosis
| Article | Year |
|---|---|
Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomyc | 2003 |